Looking for a more practical, up-to-date guide
Xiao D, Zeng L, Yao K, Kong X, Wu G, Yin Y
Although tirzepatide is not classified as a diuretic, patients may experience changes in fluid balance during treatment, primarily related to weight loss, dietary modifications, and gastrointestinal side effects
Stop and Seek Help If Any signs of allergic reactionhives, swelling, breathing difficulty (stop immediately, seek help) Severe or persistent headaches that don't respond to dose reduction Excessive daytime drowsiness affecting your ability to function Unusual mood changes or psychological symptoms You've completed your planned cycle (typically 4-6 weeks) Your healthcare provider recommends discontinuation DSIP is a research peptide, not an FDA-approved medication